Comella CL - Search Results

1

Postural Directionality and Head Tremor in Cervical Dystonia.

Chen Q, Vu JP, Cisneros E, Benadof CN, Zhang Z, Barbano RL, Goetz CG, Jankovic J, Jinnah HA, Perlmutter JS, Appelbaum MI, Stebbins GT, Comella CL, Peterson DA. Chen Q, et al. Among authors: comella cl. Tremor Other Hyperkinet Mov (N Y). 2020 Jan 20;10. doi: 10.7916/tohm.v0.745. eCollection 2020. Tremor Other Hyperkinet Mov (N Y). 2020. PMID: 32015932 Free PMC article.

2

Rating scales for dystonia: a multicenter assessment.

Comella CL, Leurgans S, Wuu J, Stebbins GT, Chmura T; and The Dystonia Study Group. Comella CL, et al. Mov Disord. 2003 Mar;18(3):303-312. doi: 10.1002/mds.10377. Mov Disord. 2003. PMID: 12621634 Clinical Trial.

3

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.

Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL. Truong D, et al. Among authors: comella cl. Mov Disord. 2005 Jul;20(7):783-91. doi: 10.1002/mds.20403. Mov Disord. 2005. PMID: 15736159 Clinical Trial.

4

Long-term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay.

Brin MF, Comella CL, Jankovic J, Lai F, Naumann M; CD-017 BoNTA Study Group. Brin MF, et al. Among authors: comella cl. Mov Disord. 2008 Jul 30;23(10):1353-60. doi: 10.1002/mds.22157. Mov Disord. 2008. PMID: 18546321 Clinical Trial.

5

Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.

Marder K, Zhao H, Eberly S, Tanner CM, Oakes D, Shoulson I; Huntington Study Group. Marder K, et al. Neurology. 2009 Aug 4;73(5):385-92. doi: 10.1212/WNL.0b013e3181b04aa2. Neurology. 2009. PMID: 19652143 Free PMC article.

6

Scales to assess sleep impairment in Parkinson's disease: critique and recommendations.

Högl B, Arnulf I, Comella C, Ferreira J, Iranzo A, Tilley B, Trenkwalder C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Schrag A, Goetz CG. Högl B, et al. Mov Disord. 2010 Dec 15;25(16):2704-16. doi: 10.1002/mds.23190. Mov Disord. 2010. PMID: 20931631 Review.

7

Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm-a randomized trial.

Jankovic J, Comella C, Hanschmann A, Grafe S. Jankovic J, et al. Mov Disord. 2011 Jul;26(8):1521-8. doi: 10.1002/mds.23658. Epub 2011 Apr 22. Mov Disord. 2011. PMID: 21520284 Clinical Trial.

8

Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia.

Comella CL, Jankovic J, Truong DD, Hanschmann A, Grafe S; U.S. XEOMIN Cervical Dystonia Study Group. Comella CL, et al. J Neurol Sci. 2011 Sep 15;308(1-2):103-9. doi: 10.1016/j.jns.2011.05.041. Epub 2011 Jul 18. J Neurol Sci. 2011. PMID: 21764407 Clinical Trial.

9

Rationale and design of a prospective study: Cervical Dystonia Patient Registry for Observation of OnaBotulinumtoxinA Efficacy (CD PROBE).

Jankovic J, Adler CH, Charles PD, Comella C, Stacy M, Schwartz M, Sutch SM, Brin MF, Papapetropoulos S. Jankovic J, et al. BMC Neurol. 2011 Nov 4;11:140. doi: 10.1186/1471-2377-11-140. BMC Neurol. 2011. PMID: 22054223 Free PMC article.

10

Tai chi for patients with Parkinson's disease.

Corcos DM, Comella CL, Goetz CG. Corcos DM, et al. Among authors: comella cl. N Engl J Med. 2012 May 3;366(18):1737-8; author reply 1738. doi: 10.1056/NEJMc1202921. N Engl J Med. 2012. PMID: 22551137 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

189 results

Search Page